Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.59%89.91B | 27.88%393.31B | 53.44%82.8B | 8.24%307.55B | 32.00%104.3B | 16.94%77B | -9.09%72.3B | -9.69%53.96B | 11.96%284.14B | 7.49%79.02B |
| Cost of revenue | 14.16%28.65B | 17.02%115.74B | 33.66%25.1B | -0.72%98.91B | 18.65%32.97B | 7.01%24.34B | -16.96%22.82B | -13.12%18.78B | -0.14%99.63B | -2.49%27.79B |
| Gross profit | 6.17%61.26B | 33.04%277.57B | 64.00%57.7B | 13.08%208.64B | 39.24%71.33B | 22.19%52.66B | -4.95%49.48B | -7.74%35.18B | 19.80%184.51B | 13.80%51.22B |
| Operating expense | 2,330.00%243M | 221.62%119M | 25.00%10M | 5.71%37M | 11.11%10M | 0.00%9M | 11.11%10M | 0.00%8M | -23.91%35M | -18.18%9M |
| Depreciation and amortization | 2,330.00%243M | 221.62%119M | 25.00%10M | 5.71%37M | 11.11%10M | 0.00%9M | 11.11%10M | 0.00%8M | -23.91%35M | -18.18%9M |
| -Depreciation | 2,330.00%243M | 221.62%119M | 25.00%10M | 5.71%37M | 11.11%10M | 0.00%9M | 11.11%10M | 0.00%8M | -23.91%35M | -18.18%9M |
| Operating profit | 5.77%61.02B | 33.00%277.45B | 64.01%57.69B | 13.08%208.61B | 39.25%71.32B | 22.20%52.65B | -4.95%49.47B | -7.75%35.17B | 19.81%184.47B | 13.81%51.22B |
| Net non-operating interest income (expenses) | 25.00%10M | 6.33%84M | -33.33%8M | 71.74%79M | 40.00%21M | -11.11%8M | 245.45%38M | 9.09%12M | -6.12%46M | 15.38%15M |
| Non-operating interest income | 25.00%10M | 6.33%84M | -33.33%8M | 71.74%79M | 40.00%21M | -11.11%8M | 245.45%38M | 9.09%12M | -6.12%46M | 15.38%15M |
| Net investment income | -2,605.13%-1.06B | 191.23%811M | -103.85%-39M | -230.54%-889M | -46.17%260M | 0.11%-1.75B | -142.36%-413M | 4.00%1.01B | 163.47%681M | 4,290.91%483M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 10M | ||||||||
| Income from associates and other participating interests | -8.60%85M | 89.36%267M | 138.46%93M | -26.56%141M | 6,800.00%67M | -75.00%7M | -61.64%28M | -57.61%39M | -58.35%192M | -104.76%-1M |
| Special income (charges) | -109.70%-346M | 89.80%-797M | -650.00%-165M | -1,888.79%-7.82B | -137.88%-214M | -9,134.15%-7.57B | 57.14%-9M | 12.00%-22M | 321.83%437M | 1,586.84%565M |
| Less:Impairment of capital assets | 2,330.00%243M | 221.62%119M | 25.00%10M | 5.71%37M | 11.11%10M | 0.00%9M | 11.11%10M | 0.00%8M | -23.91%35M | -18.18%9M |
| Less:Other special charges | 109.70%346M | 177.70%797M | 650.00%165M | 157.40%287M | 137.88%214M | 121.05%42M | -57.14%9M | -12.00%22M | -353.81%-500M | -1,586.84%-565M |
| Less:Write off | ---- | --0 | ---- | 11,852.38%7.53B | --0 | ---- | ---- | ---- | --63M | --0 |
| Other non-operating income (expenses) | 272.16%722M | -33.75%1.07B | 45.86%194M | 54.71%1.61B | -46.15%203M | 1,052.05%841M | -12.02%432M | 34.34%133M | -32.64%1.04B | 47.27%377M |
| Income before tax | 0.58%33.65B | 46.75%168.15B | 84.45%33.46B | 1.59%114.58B | 41.94%46.45B | -2.87%21.88B | -19.23%28.11B | -20.22%18.14B | 22.26%112.79B | 14.78%32.73B |
| Income tax | 2.00%9.88B | 45.14%44.07B | 77.14%9.69B | 1.65%30.36B | 56.29%11.01B | -2.99%5.8B | -20.40%8.09B | -18.25%5.47B | 14.90%29.87B | -9.76%7.04B |
| Net income | 0.00%23.77B | 47.34%124.08B | 87.62%23.77B | 1.56%84.21B | 38.01%35.44B | -2.83%16.08B | -18.74%20.02B | -21.05%12.67B | 25.15%82.91B | 24.02%25.68B |
| Net income continuous operations | 0.00%23.77B | 47.34%124.08B | 87.60%23.77B | 1.57%84.21B | 38.01%35.45B | -2.82%16.08B | -18.75%20.02B | -21.04%12.67B | 25.15%82.91B | 24.02%25.68B |
| Noncontrolling interests | -92.98%4M | 3,580.00%184M | 618.18%57M | -77.27%5M | 54.55%17M | 200.00%4M | -171.43%-5M | -237.50%-11M | -53.19%22M | 0.00%11M |
| Net income attributable to the company | 0.23%23.77B | 47.13%123.89B | 86.98%23.71B | 1.59%84.21B | 37.99%35.43B | -2.86%16.07B | -18.71%20.03B | -20.93%12.68B | 25.20%82.89B | 24.04%25.67B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 0.23%23.77B | 47.13%123.89B | 86.98%23.71B | 1.59%84.21B | 37.99%35.43B | -2.86%16.07B | -18.71%20.03B | -20.93%12.68B | 25.20%82.89B | 24.04%25.67B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.17%219.23 | 47.08%1.14K | 86.91%218.85 | 1.54%777.29 | 37.94%326.99 | -2.91%148.34 | -18.73%184.87 | -20.96%117.09 | 25.14%765.47 | 24.01%237.05 |
| Diluted earnings per share | -0.14%218.54 | 47.11%1.14K | 87.56%218.85 | 1.48%774.26 | 37.82%325.61 | -2.95%147.79 | -18.78%184.18 | -20.99%116.68 | 25.17%762.98 | 23.99%236.26 |
| Dividend per share | 0 | 34.53%413 | 0 | 0.55%307 | 9.31%231 | 0 | -19.15%76 | 0 | 13.37%305.3333 | 4.11%211.3333 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |